A novel benzazepinone sodium channel blocker with oral efficacy in a rat model of neuropathic pain

A series of benzazepinones were synthesized and evaluated as Nav1.7 sodium channel blockers. Compound 30 from this series displayed potent channel block, good oral bioavailability, and dose-dependent oral efficacy in a rat model of neuropathic pain.